Lobbying client
P&G PHARMACEUTICALS, INC.
Develop and market prescription products
Filings
5
Filed by
1
Reported in-house
—
Reported by firms
$50,000
Filings
5 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2009
|
CAPITOL COUNSEL LLC | — reported |
|
2nd Quarter - Amendment 2nd Quarter 2009
|
CAPITOL COUNSEL LLC | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2009
|
CAPITOL COUNSEL LLC | — reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2009
|
CAPITOL COUNSEL LLC | $50,000 reported |
|
Registration 2nd Quarter 2009
|
CAPITOL COUNSEL LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| CAPITOL COUNSEL LLC | 3 | $50,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 4 |
| Medicare/Medicaid | MMM | 4 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.